No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3bwiA, 1.0000, 0.00, 1.000, 423, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH AN ACETATE ION BOUND AT THE ACTIVE SITE
2, 3qw5A, 0.9990, 0.23, 1.000, 423, 423, CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRGF
3, 3c8bA, 0.9990, 0.23, 1.000, 423, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGI
4, 3ddbA, 0.9987, 0.26, 1.000, 423, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A SUBSTRATE ANALOG PEPTIDE
5, 3ddaA, 0.9981, 0.32, 1.000, 423, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A SNAP-25 PEPTIDE
6, 3c89A, 0.9967, 0.22, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGM
7, 3c88A, 0.9967, 0.22, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGC
8, 3c8aA, 0.9963, 0.27, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH INHIBITORY PEPTIDE RRGL
9, 3qw8A, 0.9961, 0.29, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR CRGC
10, 3qw6A, 0.9943, 0.44, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RYGC
11, 3qw7A, 0.9931, 0.52, 1.000, 422, 422, CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRFC
12, 4el4A, 0.9921, 0.79, 0.995, 425, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S/C165S DOUBLE MUTANT
13, 4ej5A, 0.9918, 0.89, 1.000, 433, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A WILD-TYPE
14, 4elcA, 0.9893, 0.72, 0.998, 432, 422, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134 MUTANT WITH MTSEA MODIFIED CYS-165
15, 5vgxA, 0.9869, 0.84, 0.995, 421, 421, STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH HG BOUND
16, 4zjxA, 0.9835, 0.36, 0.998, 417, 417, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A NOVEL CYCLIC PEPTIDE INHIBITOR
17, 4kufA, 0.9831, 0.86, 0.981, 425, 420, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134 MUTANT WITH MTSEA MODIFIED CYS-165 CAUSING STRETCH DISORDER
18, 3booA, 0.9830, 0.40, 0.995, 419, 417, STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH AN INHIBITORY PEPTIDE BOUND
19, 4ks6A, 0.9826, 1.04, 0.986, 428, 421, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S MUTANT WITH COVALENT INHIBITOR THAT MODIFIES CYS-165 CAUSING DISORDER IN 166-174 STRETCH
20, 5vgvA, 0.9821, 1.08, 0.995, 421, 420, STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH CU BOUND
21, 4ktxA, 0.9809, 1.38, 0.998, 428, 423, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S MUTANT WITH COVALENT INHIBITOR THAT MODIFIES CYS-165 CAUSING DISORDER IN 167-174 STRETCH
22, 3bonA, 0.9795, 0.48, 0.998, 416, 416, STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A WITH ZN2+ COFACTOR BOUND
23, 3bokA, 0.9794, 0.49, 0.998, 416, 416, STRUCTURE OF THE C. BOTULINUM NEUROTOXIN SEROTYPE A APO- ENZYME
24, 2g7nA, 0.9769, 0.51, 0.952, 415, 415, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
25, 1xtfB, 0.9544, 1.57, 0.988, 427, 415, NEUROTOXIN BONT/A E224Q Y366F MUTANT
26, 1xtgA, 0.9528, 1.87, 0.964, 424, 418, CRYSTAL STRUCTURE OF NEUROTOXIN BONT/A COMPLEXED WITH SYNAPTOSOMAL-ASSOCIATED PROTEIN 25
27, 1xtfA, 0.9483, 1.91, 0.988, 427, 415, NEUROTOXIN BONT/A E224Q Y366F MUTANT
28, 2iseB, 0.9476, 1.87, 0.993, 421, 414, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM A
29, 2iseA, 0.9476, 1.87, 0.993, 421, 414, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM A
30, 2w2dC, 0.9447, 1.90, 0.976, 435, 414, CRYSTAL STRUCTURE OF A CATALYTICALLY ACTIVE NON-TOXIC ENDOPEPTIDASE DERIVATIVE OF CLOSTRIDIUM BOTULINUM TOXIN A
31, 3zurA, 0.9443, 1.82, 0.971, 847, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC0-A-SNAP25-HN-A
32, 2w2dA, 0.9441, 1.83, 0.976, 436, 413, CRYSTAL STRUCTURE OF A CATALYTICALLY ACTIVE NON-TOXIC ENDOPEPTIDASE DERIVATIVE OF CLOSTRIDIUM BOTULINUM TOXIN A
33, 3zusD, 0.9432, 1.84, 0.976, 853, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC-A-SNAP23-HN-A
34, 3v0bA, 0.9432, 1.83, 0.973, 1280, 413, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
35, 3v0aA, 0.9432, 1.83, 0.973, 1280, 413, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
36, 3zusA, 0.9430, 1.84, 0.976, 851, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC-A-SNAP23-HN-A
37, 3zusC, 0.9428, 1.86, 0.976, 852, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC-A-SNAP23-HN-A
38, 3zurB, 0.9428, 1.84, 0.971, 843, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC0-A-SNAP25-HN-A
39, 3zusB, 0.9427, 1.86, 0.973, 851, 413, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE A-SNARE23 DERIVATIVE LC-A-SNAP23-HN-A
40, 3v0cA, 0.9419, 2.02, 0.969, 1277, 414, 4.3 ANGSTROM CRYSTAL STRUCTURE OF AN INACTIVE BONT/A (E224Q/R363A/Y366F)
41, 2nz9B, 0.9419, 2.03, 0.976, 1267, 414, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
42, 2nz9A, 0.9419, 2.05, 0.976, 1267, 414, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
43, 2nyyA, 0.9417, 2.05, 0.976, 1267, 414, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
44, 3btaA, 0.9415, 1.94, 0.973, 1277, 413, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A
45, 2ishB, 0.9409, 1.71, 0.990, 416, 409, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM C
46, 2ishA, 0.9396, 1.66, 1.000, 416, 408, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM C
47, 2g7pA, 0.9375, 1.20, 0.926, 411, 403, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
48, 2g7qA, 0.9370, 1.20, 0.926, 411, 403, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
49, 2g7pB, 0.9364, 1.35, 0.933, 409, 403, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
50, 2isgB, 0.9354, 2.17, 0.990, 416, 412, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM B
51, 2isgA, 0.9352, 2.21, 0.990, 416, 412, BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM B
52, 2g7qB, 0.9348, 1.22, 0.933, 409, 402, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
53, 3ds9A, 0.9269, 0.90, 0.985, 398, 397, A POTENT PEPTIDOMIMETIC INHIBITOR OF BOTULINUM NEUROTOXIN SEROTYPE A HAS A VERY DIFFERENT CONFORMATION THAN SNAP-25 SUBSTRATE
54, 3qizA, 0.9181, 1.37, 0.977, 399, 397, CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-2
55, 2g7kA, 0.9176, 1.02, 0.947, 401, 393, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
56, 3qixA, 0.9134, 1.16, 0.982, 396, 394, CRYSTAL STRUCTURE OF BONT/A LC WITH ZINC BOUND
57, 3qj0A, 0.9129, 1.15, 0.982, 395, 393, CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-3
58, 3dseA, 0.9125, 1.19, 0.980, 394, 393, A POTENT PEPTIDOMIMETIC INHIBITOR OF BOTULINUM NEUROTOXIN SEROTYPE A HAS A VERY DIFFERENT CONFORMATION THAN SNAP-25 SUBSTRATE
59, 2g7kB, 0.9116, 1.04, 0.946, 399, 391, STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS
60, 3nf3A, 0.9093, 0.91, 0.990, 392, 390, CRYSTAL STRUCTURE OF BONT/A LC WITH JTH-NB-7239 PEPTIDE
61, 2imcA, 0.9093, 1.20, 0.990, 401, 391, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN RESIDUES 1-424
62, 2imcB, 0.9088, 1.52, 0.992, 405, 393, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN RESIDUES 1-424
63, 2ilpA, 0.9044, 1.38, 0.992, 407, 391, CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY 4- CHLOROCINNAMIC HYDROXAMATE
64, 2ilpB, 0.9042, 1.45, 0.997, 407, 391, CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY 4- CHLOROCINNAMIC HYDROXAMATE
65, 3qiyA, 0.9036, 1.15, 0.982, 391, 389, CRYSTAL STRUCTURE OF BONT/A LC COMPLEXED WITH HYDROXAMATE-BASED INHIBITOR PT-1
66, 1z7hA, 0.9023, 2.37, 0.298, 426, 410, 2.3 ANGSTROM CRYSTAL STRUCTURE OF TETANUS NEUROTOXIN LIGHT CHAIN
67, 2etfB, 0.9021, 2.73, 0.312, 436, 416, CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN
68, 1s0dA, 0.9003, 2.61, 0.316, 1287, 412, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.5
69, 1g9dA, 0.9003, 2.61, 0.316, 1287, 412, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 2)
70, 1g9aA, 0.9001, 2.61, 0.313, 1287, 412, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 3)
71, 1s0gA, 0.9000, 2.61, 0.316, 1288, 412, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B APO FORM
72, 1g9bA, 0.9000, 2.61, 0.313, 1287, 412, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 1)
73, 1epwA, 0.8999, 2.62, 0.316, 1287, 412, CRYSTAL STRUCTURE OF CLOSTRIDIUM NEUROTOXIN TYPE B
74, 3zuqA, 0.8998, 2.59, 0.316, 850, 411, CRYSTAL STRUCTURE OF AN ENGINEERED BOTULINUM NEUROTOXIN TYPE B-DERIVATIVE LC-B-GS-HN-B
75, 1i1eA, 0.8998, 2.63, 0.313, 1287, 412, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH DOXORUBICIN
76, 5n0cA, 0.8997, 2.55, 0.294, 1293, 411, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
77, 1s0fA, 0.8996, 2.73, 0.312, 1276, 414, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 7.0
78, 2np0A, 0.8994, 2.52, 0.315, 1289, 410, CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN
79, 1s0eA, 0.8994, 2.63, 0.316, 1287, 412, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 6.0
80, 1s0cA, 0.8994, 2.62, 0.316, 1287, 412, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 5.0
81, 1g9cA, 0.8994, 2.71, 0.312, 1287, 414, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH AN INHIBITOR (EXPERIMENT 4)
82, 1s0bA, 0.8992, 2.63, 0.316, 1287, 412, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE B AT PH 4.0
83, 5n0cB, 0.8990, 2.56, 0.294, 1286, 411, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GM1A
84, 5n0bA, 0.8987, 2.57, 0.294, 1280, 411, CRYSTAL STRUCTURE OF THE TETANUS NEUROTOXIN IN COMPLEX WITH GD1A
85, 5v8rB, 0.8981, 1.57, 0.995, 405, 389, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
86, 3qixB, 0.8977, 0.94, 0.979, 385, 385, CRYSTAL STRUCTURE OF BONT/A LC WITH ZINC BOUND
87, 5v8rA, 0.8970, 1.27, 0.995, 402, 386, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
88, 2etfA, 0.8970, 2.75, 0.315, 431, 413, CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN
89, 2imaA, 0.8964, 1.31, 0.992, 402, 387, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY 24-DICHLOROCINNAMIC HYDROXAMATE
90, 2imaB, 0.8963, 1.43, 0.997, 403, 387, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY 24-DICHLOROCINNAMIC HYDROXAMATE
91, 1f31A, 0.8956, 2.61, 0.311, 1280, 409, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN B COMPLEXED WITH A TRISACCHARIDE
92, 4hevA, 0.8950, 1.38, 0.992, 397, 386, CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY ADAMANTANE HYDROXAMATE
93, 5v8pB, 0.8945, 1.46, 0.997, 402, 386, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
94, 2imbB, 0.8944, 1.48, 0.995, 402, 386, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY L-ARGININE HYDROXAMATE
95, 2imbA, 0.8920, 1.09, 0.995, 393, 383, CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY L-ARGININE HYDROXAMATE
96, 2xhlA, 0.8919, 2.44, 0.318, 430, 406, STRUCTURE OF A FUNCTIONAL DERIVATIVE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE B
97, 4hevB, 0.8918, 1.10, 0.992, 393, 383, CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY ADAMANTANE HYDROXAMATE
98, 2qn0A, 0.8916, 2.69, 0.322, 429, 407, STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 LIGHT CHAIN PROTEASE
99, 3debA, 0.8913, 2.78, 0.325, 432, 409, CRYSTAL STRUCTURE OF APO FORM (ZINC REMOVED) OF THE BOTULINUM NEUROTOXIN TYPE C LIGHT CHAIN
100, 6bvdA, 0.8891, 2.46, 0.328, 429, 403, STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE HA LIGHT CHAIN 
101, 5bqnA, 0.8889, 2.96, 0.339, 838, 413, CRYSTAL STRUCTURE OF THE LHN FRAGMENT OF BOTULINUM NEUROTOXIN TYPE D MUTANT H233Y E230Q
102, 1f82A, 0.8880, 2.61, 0.315, 424, 406, BOTULINUM NEUROTOXIN TYPE B CATALYTIC DOMAIN
103, 5bqmA, 0.8873, 3.00, 0.341, 442, 413, CRYSTAL STRUCTURE OF SXN101959 A CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE D DERIVATIVE AND TARGETED SECRETION INHIBITOR
104, 6bvdB, 0.8871, 2.39, 0.328, 425, 402, STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE HA LIGHT CHAIN 
105, 5bqmC, 0.8865, 2.90, 0.341, 443, 411, CRYSTAL STRUCTURE OF SXN101959 A CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE D DERIVATIVE AND TARGETED SECRETION INHIBITOR
106, 5v8uA, 0.8849, 1.04, 0.989, 389, 379, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
107, 5v8pA, 0.8845, 0.81, 0.995, 388, 378, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
108, 3fieA, 0.8798, 2.25, 0.329, 407, 398, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH1)
109, 5v8uB, 0.8783, 0.77, 0.989, 385, 375, SMALL MOLECULE INHIBITOR ABS-143 BOUND TO THE BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN
110, 2a8aA, 0.8765, 2.18, 0.333, 405, 396, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F LIGHT CHAIN
111, 2fpqA, 0.8763, 2.48, 0.361, 413, 399, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE D LIGHT CHAIN
112, 3ffzA, 0.8755, 2.51, 0.332, 1246, 400, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
113, 3ffzB, 0.8748, 2.53, 0.335, 1238, 400, DOMAIN ORGANIZATION IN CLOSTRIDIUM BUTULINUM NEUROTOXIN TYPE E IS UNIQUE: ITS IMPLICATION IN FASTER TRANSLOCATION
114, 3fiiA, 0.8736, 2.17, 0.335, 403, 394, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH2)
115, 3fieB, 0.8736, 2.13, 0.336, 402, 393, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F CATALYTIC DOMAIN WITH AN INHIBITOR (INH1)
116, 1t3cB, 0.8689, 2.43, 0.343, 409, 396, CLOSTRIDIUM BOTULINUM TYPE E CATALYTIC DOMAIN E212Q MUTANT
117, 1zkwB, 0.8680, 2.45, 0.343, 409, 396, CRYSTAL STRUCTURE OF ARG347ALA MUTANT OF BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
118, 1zkwA, 0.8678, 2.55, 0.344, 411, 398, CRYSTAL STRUCTURE OF ARG347ALA MUTANT OF BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
119, 1yvgA, 0.8675, 1.78, 0.306, 397, 385, STRUCTURAL ANALYSIS OF THE CATALYTIC DOMAIN OF TETANUS NEUROTOXIN
120, 1zn3A, 0.8673, 2.56, 0.344, 411, 398, CRYSTAL STRUCTURE OF GLU335ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E
121, 1t3cA, 0.8672, 2.57, 0.344, 411, 398, CLOSTRIDIUM BOTULINUM TYPE E CATALYTIC DOMAIN E212Q MUTANT
122, 4zktE, 0.8651, 2.53, 0.333, 1235, 396, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
123, 4zktA, 0.8646, 2.53, 0.333, 1235, 396, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
124, 4zktC, 0.8644, 2.54, 0.333, 1235, 396, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
125, 3d3xB, 0.8641, 2.45, 0.343, 407, 394, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE E CATALYTIC DOMAIN IN COMPLEX WITH SNAP-25 SUBSTRATE PEPTIDE
126, 3d3xA, 0.8631, 2.54, 0.347, 407, 395, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE E CATALYTIC DOMAIN IN COMPLEX WITH SNAP-25 SUBSTRATE PEPTIDE
127, 1zb7A, 0.8554, 2.36, 0.360, 414, 386, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE G LIGHT CHAIN
128, 4j1lA, 0.8552, 1.74, 0.317, 391, 379, MUTANT ENDOTOXIN TENT
129, 2a97B, 0.8541, 2.01, 0.345, 392, 383, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F
130, 2a97A, 0.8529, 2.03, 0.347, 392, 383, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE F
131, 1zkxA, 0.8516, 2.38, 0.354, 400, 387, CRYSTAL STRUCTURE OF GLU158ALA/THR159ALA/ASN160ALA- A TRIPLE MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
132, 1zl6A, 0.8511, 2.40, 0.351, 400, 387, CRYSTAL STRUCTURE OF TYR350ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
133, 1t3aA, 0.8510, 2.39, 0.354, 400, 387, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E CATALYTIC DOMAIN
134, 1zl5A, 0.8505, 2.40, 0.351, 400, 387, CRYSTAL STRUCTURE OF GLU335GLN MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
135, 1t3aB, 0.8500, 2.38, 0.355, 398, 386, CRYSTAL STRUCTURE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E CATALYTIC DOMAIN
136, 6f47A, 0.8392, 2.66, 0.329, 413, 386, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN X
137, 1zl6B, 0.8344, 2.15, 0.352, 387, 375, CRYSTAL STRUCTURE OF TYR350ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
138, 1zkxB, 0.8337, 2.18, 0.352, 387, 375, CRYSTAL STRUCTURE OF GLU158ALA/THR159ALA/ASN160ALA- A TRIPLE MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
139, 1zl5B, 0.8329, 2.19, 0.352, 387, 375, CRYSTAL STRUCTURE OF GLU335GLN MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN E CATALYTIC DOMAIN
140, 1zn3B, 0.8323, 2.20, 0.352, 387, 375, CRYSTAL STRUCTURE OF GLU335ALA MUTANT OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE E
141, 6f4eA, 0.8320, 2.81, 0.314, 418, 385, CRYSTAL STRUCTURE OF THE ZINC-FREE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN X
142, 3vuoA, 0.7522, 2.96, 0.237, 1151, 355, CRYSTAL STRUCTURE OF NONTOXIC NONHEMAGGLUTININ SUBCOMPONENT (NTNHA) FROM CLOSTRIDIUM BOTULINUM SEROTYPE D STRAIN 4947
143, 3v0bB, 0.7497, 2.99, 0.251, 1150, 355, 3.9 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
144, 3v0aB, 0.7497, 2.99, 0.251, 1150, 355, 2.7 ANGSTROM CRYSTAL STRUCTURE OF BONT/AI IN COMPLEX WITH NTNHA
145, 4zktF, 0.7317, 2.82, 0.229, 1114, 345, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
146, 4zktB, 0.7315, 2.82, 0.229, 1114, 345, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
147, 4zktD, 0.7314, 2.82, 0.229, 1114, 345, CRYSTAL STRUCTURE OF THE PROGENITOR M COMPLEX OF CLOSTRIDIUM BOTULINUM TYPE E NEUROTOXIN
148, 3k3qB, 0.5429, 1.49, 0.975, 238, 236, CRYSTAL STRUCTURE OF A LLAMA ANTIBODY COMPLEXED WITH THE C. BOTULINUM NEUROTOXIN SEROTYPE A CATALYTIC DOMAIN
149, 1e1hC, 0.5226, 1.99, 0.961, 235, 231, CRYSTAL STRUCTURE OF RECOMBINANT BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN SELF-INHIBITING ZN ENDOPEPTIDASE.
150, 1e1hA, 0.5226, 1.99, 0.961, 235, 231, CRYSTAL STRUCTURE OF RECOMBINANT BOTULINUM NEUROTOXIN TYPE A LIGHT CHAIN SELF-INHIBITING ZN ENDOPEPTIDASE.
